ArticleJournal of the American Society of Nephrology : JASN2011
Targeting complement C5 in atypical hemolytic uremic syndrome.
Article in Journal of the American Society of Nephrology : JASN, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 23 citations in OpenAlex.
- Article
- Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome.The Korean journal of internal medicine · 2020Review
- A case of atypical hemolytic uremic syndrome in a second renal transplant.Journal of nephrology · 2018Article
- A Single-Domain Antibody Targeting Complement Component C5 Acts as a Selective Inhibitor of the Terminal Pathway of the Complement System and Thus Functionally Mimicks the C-Terminal Domain of theFrontiers in immunology · 2018Article
- Complement component 5 promotes lethal thrombosis.Scientific reports · 2017Article
- Abrogation of immune complex glomerulonephritis by native carboxypeptidase and pharmacological antagonism of the C5a receptor.Cellular & molecular immunology · 2016Article
- Hemolytic uremic syndrome.Seminars in immunopathology · 2014Review
- Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.Clinical journal of the American Society of Nephrology : CJASN · 2013Article
- The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H-deficient mice.Kidney international · 2012Article
- Treatment of atypical uraemic syndrome in the era of eculizumab.Clinical kidney journal · 2012Article
- Atypical hemolytic uremic syndrome.Orphanet journal of rare diseases · 2011Review
- Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies.Case reports in oncologyArticle
Corrections and comments
- Comment on
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.